Journal of Clinical Endocrinology & Metabolism, Vol 71, 1288-1293, Copyright © 1990 by Endocrine Society

ARTICLES

Estrogen preserves a normal intestinal responsiveness to 1,25- dihydroxyvitamin D3 in oophorectomized women

C Gennari, D Agnusdei, P Nardi and R Civitelli
Institute of Medical Semeiotics, University of Siena School of Medicine, Italy.

Estrogen treatment improves calcium malabsorption induced by surgical or natural menopause, but the mechanisms involved are still under debate, with both increased production of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] and improved peripheral responsiveness to the steroid having been proposed. To address this issue, we studied the effect of short term administration of 1,25-(OH)2D3 (1 microgram/day for 7 days) on intestinal fractional absorption of 47Ca (47Ca FA) and vertebral bone density, measured by dual photon absorptiometry, in 14 premenopausal women (aged 31-50 yr) before and 6 months after oophorectomy. After surgery, patients were randomly allocated to a 6- month treatment with either conjugated estrogens (0.625 mg/day; n = 7) or placebo (n = 7). Oophorectomy caused a decrease in both basal 47Ca FA (-40.8 +/- 23.4%; P = 0.004) and vertebral bone density (-7.21 +/- 1.20%; P less than 0.001) in the placebo group. Estrogen replacement prevented these changes and increased basal serum 1,25-(OH)2D3 (+10.3 +/- 10.9%; P = 0.047), whereas a detectable but not significant decrease was observed in the control group (-8.8 +/- 10.5%; P = 0.07). Assessment of 47Ca FA before and after 1,25-(OH)2D3 administration revealed a similar degree of responsiveness to the steroid in the estrogen-treated women before and at the end of the study period (45.8 +/- 6.9% vs. 42.9% +/- 14.9% from basal, respectively; P = 0.142), but a blunted response to 1,25-(OH)2D3 was observed in the placebo group at 6 months (27.9 +/- 17.7%) compared to the result obtained before surgery (36.7 +/- 9.1%; P = 0.032). Multifactor analysis of variance revealed that the effects of estrogen and 1,25-(OH)2D3 on 47Ca FA were independent of basal serum 1,25-(OH)2D3 levels. On the other hand, calcitriol administration increased serum 1,25-(OH)2D3 to a similar extent before and 6 months after surgery in the placebo group (24.2 +/- 18.3% vs. 34.7 +/- 16.7% from basal, respectively; P = 0.484) as well as in the estrogen-treated women (34.2 +/- 17.2% vs. 26.6 +/- 15.45%; P = 0.302). The significant impairment of 1,25-(OH)2D3 stimulation of 47Ca FA in spite of increased levels of circulating 1,25-(OH)2D3 in the untreated women is suggestive of an end-organ resistance to the vitamin D metabolite in a hypoestrogenic condition, which can be prevented by hormone replacement, and supports the hypothesis of a vitamin D- independent action of estrogen on intestinal calcium absorption.

This article has been cited by other articles:

				L. A. Gilad and B. Schwartz Association of estrogen receptor {beta} with plasma-membrane caveola components: implication in control of vitamin D receptor J. Mol. Endocrinol., June 1, 2007; 38(6): 603 - 618. [Abstract] [Full Text] [PDF]

				Y. Song and J. C. Fleet Intestinal Resistance to 1,25 Dihydroxyvitamin D in Mice Heterozygous for the Vitamin D Receptor Knockout Allele Endocrinology, March 1, 2007; 148(3): 1396 - 1402. [Abstract] [Full Text] [PDF]

				K. Tudpor, N. Charoenphandhu, W. Saengamnart, and N. Krishnamra Long-Term Prolactin Exposure Differentially Stimulated the Transcellular and Solvent Drag-Induced Calcium Transport in the Duodenum of Ovariectomized Rats Experimental Biology and Medicine, December 1, 2005; 230(11): 836 - 844. [Abstract] [Full Text] [PDF]

				L. A. Gilad, T. Bresler, J. Gnainsky, P. Smirnoff, and B. Schwartz Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells J. Endocrinol., June 1, 2005; 185(3): 577 - 592. [Abstract] [Full Text] [PDF]

				B.E. C. Nordin and A. G. Need The Relation Between Serum Calcidiol and Calcitriol IBMS BoneKEy, May 1, 2005; 2(5): 7 - 16. [Full Text] [PDF]

				Y. Song and J. C. Fleet 1,25 Dihydroxycholecalciferol-Mediated Calcium Absorption and Gene Expression Are Higher in Female than in Male Mice J. Nutr., August 1, 2004; 134(8): 1857 - 1861. [Abstract] [Full Text] [PDF]

				M. Cifuentes, J. P. Advis, and S. A. Shapses Estrogen Prevents the Reduction in Fractional Calcium Absorption Due to Energy Restriction in Mature Rats J. Nutr., August 1, 2004; 134(8): 1929 - 1934. [Abstract] [Full Text] [PDF]

				B. H. Arjmandi, D. A. Khalil, B. J. Smith, E. A. Lucas, S. Juma, M. E. Payton, and R. A. Wild Soy Protein Has a Greater Effect on Bone in Postmenopausal Women Not on Hormone Replacement Therapy, as Evidenced by Reducing Bone Resorption and Urinary Calcium Excretion J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1048 - 1054. [Abstract] [Full Text] [PDF]

				B. L. Riggs, S. Khosla, and L. J. Melton III Sex Steroids and the Construction and Conservation of the Adult Skeleton Endocr. Rev., June 1, 2002; 23(3): 279 - 302. [Abstract] [Full Text] [PDF]

				D. T. Villareal, E. F. Binder, D. B. Williams, K. B. Schechtman, K. E. Yarasheski, and W. M. Kohrt Bone Mineral Density Response to Estrogen Replacement in Frail Elderly Women: A Randomized Controlled Trial JAMA, August 15, 2001; 286(7): 815 - 820. [Abstract] [Full Text] [PDF]

				J. C. Gallagher, S. E. Fowler, J. R. Detter, and S. S. Sherman Combination Treatment with Estrogen and Calcitriol in the Prevention of Age-Related Bone Loss J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3618 - 3628. [Abstract] [Full Text] [PDF]

				S. Pattanaungkul, B. L. Riggs, A. L. Yergey, N. E. Vieira, W. M. O’Fallon, and S. Khosla Relationship of Intestinal Calcium Absorption to 1,25-Dihydroxyvitamin D [1,25(OH)2D] Levels in Young Versus Elderly Women: Evidence for Age-Related Intestinal Resistance to 1,25(OH)2D Action J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4023 - 4027. [Abstract] [Full Text]

				B. Dawson-Hughes, S. S Harris, E. A Krall, and G. E Dallal Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women Am. J. Clinical Nutrition, September 1, 2000; 72(3): 745 - 750. [Abstract] [Full Text] [PDF]

				J. McIlroy, F. Dryburgh, J. Hinnie, R. Dargie, and A. Al-Rawi Lesson of the week Oestrogen and calcium homeostasis in women with hypoparathyroidism BMJ, November 6, 1999; 319(7219): 1252 - 1253. [Full Text]

				Y. Liel, S. Shany, P. Smirnoff, and B. Schwartz Estrogen Increases 1,25-Dihydroxyvitamin D Receptors Expression and Bioresponse in the Rat Duodenal Mucosa Endocrinology, January 1, 1999; 140(1): 280 - 285. [Abstract] [Full Text]

				S. Khosla, L. J. Melton III, E. J. Atkinson, W. M. O’Fallon, G. G. Klee, and B. L. Riggs Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estrogen J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2266 - 2274. [Abstract] [Full Text]

				C. Chen and D. N. Kalu Modulation of Intestinal Estrogen Receptor by Ovariectomy, Estrogen and Growth Hormone J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 328 - 333. [Abstract] [Full Text]

				S. Khosla, E. J. Atkinson, L. J. Melton III, and B. L. Riggs Effects of Age and Estrogen Status on Serum Parathyroid Hormone Levels and Biochemical Markers of Bone Turnover in Women: A Population-Based Study J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1522 - 1527. [Abstract] [Full Text] [PDF]